Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
Year: 2010
Type: review
Source: The Lancet
Author: ‡
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline, Sanofi, Brigham and Women's Hospital, Wellcome Trust, Cancer Research UK, British Heart Foundation, Bupa Foundation, University of Oxford, European Commission, University of Glasgow, Evelyn Trust, National Institutes of Health, University of California, San Diego, Medical Research Council, National Heart, Lung, and Blood Institute, Fogarty International Center
Awards: G320655365, RENEWAL: Dissecting the molecular genetic architecture of plasma lipid traits: identifying functional changes and their use in determining coronary heart disease causality, G4733990475, RENEWAL: Systematic approaches to the evaluation of emerging coronary risk markers. Large-scale epidemiological analyses of existing data and stored biological samples
OpenAlex ID: W2114408062